Loading…
Xtant Medical Holdings, Inc. is projected to rise to $0.4965 by 2027, a +18% move from its current price of $0.4199. XTNT is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.4092 | $0.4198 | $0.4308 | -0.01% |
| Jul 14 | $0.4048 | $0.4198 | $0.4354 | -0.03% |
| Jul 15 | $0.4014 | $0.4197 | $0.4389 | -0.04% |
| Jul 16 | $0.3986 | $0.4197 | $0.4419 | -0.05% |
| Jul 17 | $0.3961 | $0.4196 | $0.4445 | -0.06% |
| Jul 18 | $0.3939 | $0.4196 | $0.4469 | -0.08% |
| Jul 19 | $0.3919 | $0.4195 | $0.4491 | -0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.3919 | $0.4195 | $0.4491 | -0.09% |
| Week 2 | $0.3806 | $0.4191 | $0.4615 | -0.18% |
| Week 3 | $0.3721 | $0.4188 | $0.4712 | -0.27% |
| Week 4 | $0.3651 | $0.4184 | $0.4795 | -0.36% |
| Week 5 | $0.3589 | $0.418 | $0.4868 | -0.45% |
| Week 6 | $0.3534 | $0.4176 | $0.4935 | -0.54% |
| Week 7 | $0.3484 | $0.4172 | $0.4997 | -0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
Xtant Medical Holdings, Inc. is a healthcare company listed as XTNT, trading at $0.42 per share with a market capitalization of $58.91M and a rank of 4498.
Near-term, the 2026 forecast shows a min of $0.39, an avg of $0.42, and a max of $0.5179, with a Neutral sentiment attached to that year.
Technically, RSI14 is 40, the 50-day simple moving average sits at $0.4672 and the 200-day at $0.6039, with a defined support at $0.39 and resistance at $0.47. The 30-day trading range stretches from $0.3525 to $0.5004, indicating a tight near-term corridor.
Annualized volatility is 50, highlighting notable price movement potential relative to the current level.
A major floor 17.4% below — a decisive break under it would weaken the trend.
The nearest floor, 7.1% below — buyers have tended to step in here.
The nearest ceiling, 11.9% above — a clean break opens room to run.
A major ceiling 50.0% above — clearing it would confirm fresh momentum.
Key XTNT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of XTNT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.414 | Buy | $0.4154 | Buy |
| MA 10 | $0.417 | Buy | $0.4183 | Buy |
| MA 20 | $0.427 | Sell | $0.4277 | Sell |
| MA 50 | $0.4646 | Sell | $0.4585 | Sell |
| MA 100 | $0.5099 | Sell | $0.5035 | Sell |
| MA 200 | $0.6028 | Sell | $0.5533 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.69 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | -42.42 | Neutral |
| Williams %R (14) | -40.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | -2.33 | Sell |
| Bollinger %B (20,2) | 0.37 | Neutral |
| Stochastic %K (14) | 60.00 | Neutral |
| TRIX (15) | -0.48 | Sell |
| Awesome (5,34) | -0.03 | Sell |
| Ultimate (7,14,28) | 46.19 | Neutral |
| Momentum (10) | 0.00 | Neutral |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 0.41 | Buy |
| ADX (14) | 26.18 | Sell |
| ATR (14) | 0.01 | Info |
The near-term technical picture is Neutral, with RSI around 40 and prices managing around the 50-day moving average of $0.4672. This places the stock in a cautious zone rather than a clear up or down trend.
Prices remain below the 200-day moving average of $0.6039, suggesting limited upside momentum in the very near term. Traders will watch support at $0.39 and resistance at $0.47 as the primary bounds defining the short-term path.
The 30-day range is $0.3525 to $0.5004, framing the current activity within a relatively narrow window. Current volatility levels imply that daily moves may be more pronounced than in a more stable environment.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.39 | $0.4199 | $0.5176 | 0% | Neutral | |
| $0.3974 | $0.4965 | $0.655 | +18% | Neutral | |
| $0.4544 | $0.5828 | $0.7964 | +39% | Bullish | |
| $0.4675 | $0.6128 | $0.8607 | +46% | Bullish | |
| $0.4992 | $0.6668 | $0.9586 | +59% | Bullish | |
| $0.471 | $0.6402 | $0.9392 | +52% | Bullish | |
| $0.4698 | $0.6489 | $0.9695 | +55% | Bullish | |
| $0.532 | $0.7461 | $1.13 | +78% | Bullish | |
| $0.5856 | $0.8332 | $1.28 | +98% | Bullish | |
| $0.6469 | $0.9331 | $1.46 | +122% | Bullish | |
| $0.7536 | $1.16 | $1.92 | +175% | Bullish | |
| $1.27 | $2.16 | $3.91 | +415% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.39 | $0.4199 | $0.5019 | +0.00% |
| August 2026 | $0.3498 | $0.4123 | $0.4984 | -1.82% |
| September 2026 | $0.3498 | $0.415 | $0.507 | +0.66% |
| October 2026 | $0.3603 | $0.4298 | $0.5297 | +3.57% |
| November 2026 | $0.3556 | $0.4263 | $0.5294 | -0.81% |
| December 2026 | $0.3438 | $0.414 | $0.5176 | -2.89% |
Click any year to see its month-by-month XTNT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, XTNT could reach as high as $0.5176, with a base case around $0.4199 and support toward $0.39 — roughly 0% from $0.4199. A consolidation phase looks the most probable path here.
Expect XTNT to range from $0.3974 to $0.655 through 2027. The $0.4965 average target implies a +18% move from current prices. That is up +18% on the projected 2026 average. Price action looks broadly range-bound.
The XTNT price prediction for 2028 points to an average of $0.5828 (low $0.4544, high $0.7964) — a potential gain of +39% on today's $0.4199. Buyers look set to stay in control over this stretch.
In 2029, XTNT is projected to trade between $0.4675 and $0.8607, averaging $0.6128 — a potential gain of +46% from today's $0.4199. That is up +5% on the projected 2028 average. Momentum favours further upside here.
Xtant Medical Holdings, Inc.'s 2030 outlook centres on $0.6668, within a $0.4992 to $0.9586 range. That is up +9% on the projected 2029 average. That marks a +59% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, XTNT could reach as high as $0.9392, with a base case around $0.6402 and support toward $0.471 — roughly +52% from $0.4199. Momentum favours further upside here.
Expect XTNT to range from $0.4698 to $0.9695 through 2032. The $0.6489 average target implies a +55% move from current prices. That is up +1% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The XTNT price prediction for 2033 points to an average of $0.7461 (low $0.532, high $1.13) — a potential gain of +78% on today's $0.4199. Momentum favours further upside here.
In 2034, XTNT is projected to trade between $0.5856 and $1.28, averaging $0.8332 — a potential gain of +98% from today's $0.4199. That is up +12% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Xtant Medical Holdings, Inc.'s 2035 outlook centres on $0.9331, within a $0.6469 to $1.46 range. That is up +12% on the projected 2034 average. That marks a +122% change versus current levels. Momentum favours further upside here.
By 2040, XTNT could reach as high as $1.92, with a base case around $1.16 and support toward $0.7536 — roughly +175% from $0.4199. Buyers look set to stay in control over this stretch.
Expect XTNT to range from $1.27 to $3.91 through 2050. The $2.16 average target implies a +415% move from current prices. That is up +87% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in XTNT today (≈ 2,381.519409 XTNT) could be worth
$5,148.7
+$4,148.7 (+415%) by 2050 · US Dollar
Based on the average projected XTNT price of $2.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in XTNTwould be worth at today's price.
$1,000 invested in XTNT on Jul 10, 2025 (≈ 1,449.275367 XTNT) would be worth
$608.55
-$391.45 (-39.1%) today · 0.61× · US Dollar
Based on a XTNT entry price of $0.69 vs. today's $0.4199.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.41 | $1,024.15 | +2.4% |
| 1 month ago | $0.44 | $954.32 | -4.6% |
| 3 months ago | $0.48 | $874.79 | -12.5% |
| 6 months ago | $0.7 | $599.86 | -40.0% |
| 1 year ago | $0.69 | $608.55 | -39.1% |
| All time (5.0y) ago | $1.65 | $254.48 | -74.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our XTNT forecast.
Our base-case forecast reaches $0.84 around 2035.
Implied market cap at $0.84: $117.82M
The multi-year forecast projects a bullish trajectory after 2026, with 2026 avg of $0.42 and 2027 avg of $0.4986, max $0.6605, ROI 18.7, and Neutral sentiment for that year.
From 2028 through 2035, the averages trend higher: 2028 avg $0.5857, 2029 avg $0.6153, 2030 avg $0.6707, 2031 avg $0.6399, 2032 avg $0.6486, 2033 avg $0.7497, 2034 avg $0.8346, and 2035 avg $0.9371, with rising ROIs from 39.5% to 123.1% and Bullish sentiment through this stretch.
In the longer horizon, 2040 is forecast at avg $1.16 with ROI 175.5%, and 2050 at avg $2.17 with ROI 415.7% and max $3.96, reflecting a strong bullish tilt over the era. These figures are estimates, not guarantees. Actual results may vary.
Tap a question to reveal the answer.
Avg $0.6707; min $0.4994; max $0.9701; ROI 59.7%; sentiment BULLISH.
Forecasts show a bullish path from 2027 onward with rising averages and ROIs up to 415.7% by 2050; near-term 2026 is Neutral and current price is $0.42.
Yes. The max forecast reaches $1.15 in 2033, $1.30 in 2034, and $1.48 in 2035.
RSI14 is 40; SMA50 is $0.4672; SMA200 is $0.6039; support is $0.39 and resistance is $0.47; 30-day range is $0.3525-$0.5004.
Avg $2.17; max $3.96; ROI 415.7%; sentiment BULLISH.
Xtant Medical Holdings, Inc. Community Discussion
0Share your Xtant Medical Holdings, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.